IBDEI1X9 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30697,1,3,0)
 ;;=3^Diabetes Type 1 w/ Diabetic Neuropathy
 ;;^UTILITY(U,$J,358.3,30697,1,4,0)
 ;;=4^E10.40
 ;;^UTILITY(U,$J,358.3,30697,2)
 ;;=^5002604
 ;;^UTILITY(U,$J,358.3,30698,0)
 ;;=E10.22^^123^1582^2
 ;;^UTILITY(U,$J,358.3,30698,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30698,1,3,0)
 ;;=3^Diabetes Type 1 w/ Diabetic CKD
 ;;^UTILITY(U,$J,358.3,30698,1,4,0)
 ;;=4^E10.22
 ;;^UTILITY(U,$J,358.3,30698,2)
 ;;=^5002590
 ;;^UTILITY(U,$J,358.3,30699,0)
 ;;=E10.9^^123^1582^7
 ;;^UTILITY(U,$J,358.3,30699,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30699,1,3,0)
 ;;=3^Diabetes Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,30699,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,30699,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,30700,0)
 ;;=E11.22^^123^1582^8
 ;;^UTILITY(U,$J,358.3,30700,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30700,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic CKD
 ;;^UTILITY(U,$J,358.3,30700,1,4,0)
 ;;=4^E11.22
 ;;^UTILITY(U,$J,358.3,30700,2)
 ;;=^5002630
 ;;^UTILITY(U,$J,358.3,30701,0)
 ;;=E11.9^^123^1582^12
 ;;^UTILITY(U,$J,358.3,30701,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30701,1,3,0)
 ;;=3^Diabetes Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,30701,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,30701,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,30702,0)
 ;;=E13.22^^123^1582^1
 ;;^UTILITY(U,$J,358.3,30702,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30702,1,3,0)
 ;;=3^DM w/ Diabetic CKD,Other
 ;;^UTILITY(U,$J,358.3,30702,1,4,0)
 ;;=4^E13.22
 ;;^UTILITY(U,$J,358.3,30702,2)
 ;;=^5002671
 ;;^UTILITY(U,$J,358.3,30703,0)
 ;;=E83.30^^123^1583^26
 ;;^UTILITY(U,$J,358.3,30703,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30703,1,3,0)
 ;;=3^Phosphorus Metabolism Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,30703,1,4,0)
 ;;=4^E83.30
 ;;^UTILITY(U,$J,358.3,30703,2)
 ;;=^5002997
 ;;^UTILITY(U,$J,358.3,30704,0)
 ;;=E83.31^^123^1583^9
 ;;^UTILITY(U,$J,358.3,30704,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30704,1,3,0)
 ;;=3^Familial Hypophosphatemia
 ;;^UTILITY(U,$J,358.3,30704,1,4,0)
 ;;=4^E83.31
 ;;^UTILITY(U,$J,358.3,30704,2)
 ;;=^5002998
 ;;^UTILITY(U,$J,358.3,30705,0)
 ;;=E83.51^^123^1583^19
 ;;^UTILITY(U,$J,358.3,30705,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30705,1,3,0)
 ;;=3^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,30705,1,4,0)
 ;;=4^E83.51
 ;;^UTILITY(U,$J,358.3,30705,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,30706,0)
 ;;=E83.52^^123^1583^13
 ;;^UTILITY(U,$J,358.3,30706,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30706,1,3,0)
 ;;=3^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,30706,1,4,0)
 ;;=4^E83.52
 ;;^UTILITY(U,$J,358.3,30706,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,30707,0)
 ;;=E87.0^^123^1583^16
 ;;^UTILITY(U,$J,358.3,30707,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30707,1,3,0)
 ;;=3^Hyperosmolality and Hypernatremia
 ;;^UTILITY(U,$J,358.3,30707,1,4,0)
 ;;=4^E87.0
 ;;^UTILITY(U,$J,358.3,30707,2)
 ;;=^5003018
 ;;^UTILITY(U,$J,358.3,30708,0)
 ;;=E87.1^^123^1583^18
 ;;^UTILITY(U,$J,358.3,30708,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30708,1,3,0)
 ;;=3^Hypo-osmolality and Hyponatremia
 ;;^UTILITY(U,$J,358.3,30708,1,4,0)
 ;;=4^E87.1
 ;;^UTILITY(U,$J,358.3,30708,2)
 ;;=^5003019
 ;;^UTILITY(U,$J,358.3,30709,0)
 ;;=E87.2^^123^1583^1
 ;;^UTILITY(U,$J,358.3,30709,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30709,1,3,0)
 ;;=3^Acidosis
 ;;^UTILITY(U,$J,358.3,30709,1,4,0)
 ;;=4^E87.2
 ;;^UTILITY(U,$J,358.3,30709,2)
 ;;=^5003020
